Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 2
2018 1
2019 170
2020 281
2021 339
2022 351
2023 577
2024 473

Text availability

Article attribute

Article type

Publication date

Search Results

2,107 results

Results by year

Filters applied: . Clear all
Page 1
A large-scale machine learning analysis of inorganic nanoparticles in preclinical cancer research.
Mendes BB, Zhang Z, Conniot J, Sousa DP, Ravasco JMJM, Onweller LA, Lorenc A, Rodrigues T, Reker D, Conde J. Mendes BB, et al. Nat Nanotechnol. 2024 May 15. doi: 10.1038/s41565-024-01673-7. Online ahead of print. Nat Nanotechnol. 2024. PMID: 38750164
Owing to their distinct physical and chemical properties, inorganic nanoparticles (NPs) have shown promising results in preclinical cancer therapy, but designing and engineering them for effective therapeutic purposes remains a challenge. Although a comprehensive database of inor …
Owing to their distinct physical and chemical properties, inorganic nanoparticles (NPs) have shown promising results in preclinical cancer t …
Cryo-EM structures of the human Elongator complex at work.
Abbassi NE, Jaciuk M, Scherf D, Böhnert P, Rau A, Hammermeister A, Rawski M, Indyka P, Wazny G, Chramiec-Głąbik A, Dobosz D, Skupien-Rabian B, Jankowska U, Rappsilber J, Schaffrath R, Lin TY, Glatt S. Abbassi NE, et al. Nat Commun. 2024 May 15;15(1):4094. doi: 10.1038/s41467-024-48251-y. Nat Commun. 2024. PMID: 38750017
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1.
Fontana D, Malighetti F, Villa M, Zambon A, Gambacorti-Passerini C, Mologni L. Fontana D, et al. Leukemia. 2024 May 15. doi: 10.1038/s41375-024-02282-y. Online ahead of print. Leukemia. 2024. PMID: 38750137 No abstract available.
2,107 results